Cover Image
市場調查報告書

胰島素輸送系統的全球市場:2016年∼2020年

Global Insulin Delivery Systems Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 368257
出版日期 內容資訊 英文 81 Pages
訂單完成後即時交付
價格
Back to Top
胰島素輸送系統的全球市場:2016年∼2020年 Global Insulin Delivery Systems Market 2016-2020
出版日期: 2016年08月26日 內容資訊: 英文 81 Pages
簡介

全球胰島素輸送系統市場,預計2016年∼2020年以5.11%的年複合成長率成長。

本報告提供全球胰島素輸送系統市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

第1章 摘要整理

  • 焦點

第2章 調查範圍

  • 市場概要
  • 主要供應商產品

第3章 市場調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

  • 主要市場焦點

第5章 胰島素輸送系統的全球市場:市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 胰島素輸送系統的全球市場:各產品

  • 胰島素注射器
  • 胰島素幫浦
  • 胰島素筆針
  • 胰島素噴射注射器

第7章 胰島素輸送系統的全球市場:各終端用戶

  • 醫院
  • 糖尿病專門診所
  • 零售流通管道

第8章 胰島素輸送系統的全球市場:各地區

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第9章 胰島素輸送系統的全球市場:推動因素

第10章 推動因素的影響

第11章 胰島素輸送系統的全球市場:課題

第12章 推動因素與課題的影響

第13章 胰島素輸送系統的全球市場:趨勢

第14章 業者情勢

  • 競爭模式
  • 最近的發展

第15章 主要供應商分析

  • Novo Nordisk
  • Sanofi
  • BD
  • Eli Lilly
  • Medtronic
  • 其他卓越供應商

第16章 附錄

  • 簡稱清單

第17章 關於Technavio

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR9770

About Insulin

The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth of the market. Insulin pumps and jet injectors also require special care and maintenance, which is an additional cost burden to patients.

Technavio's analysts forecast the global insulin delivery systems market to grow at a CAGR of 5.11% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global insulin delivery systems market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of insulin delivery systems.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Insulin Delivery Systems Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Novo Nordisk
  • Sanofi
  • BD
  • Eli Lilly
  • Medtronic

Other Prominent Vendors

  • Animas
  • Beta Bionics
  • Cellnovo
  • Copernicus
  • Dance Biopharm
  • Debiotech
  • InsuJet
  • Insulet
  • MannKind
  • Owen Mumford
  • Roche
  • SHL
  • SOOIL
  • Tandem Diabetes Care
  • Valeritas
  • West Pharma
  • Ypsomed

Market driver

  • Paradigm shift of patient pool from hospitals to specialty clinics
  • For a full, detailed list, view our report

Market challenge

  • High cost of insulin devices and competitive pricing scenario
  • For a full, detailed list, view our report

Market trend

  • Inhalers to revolutionize insulin delivery
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Global insulin syringes market
  • Global insulin pumps market
  • Global insulin pens market
  • Global insulin jet injectors market

PART 07: Market segmentation by end-user

  • Hospitals
  • Specialty diabetic clinics
  • Retail channels

PART 08: Geographical segmentation

  • Insulin delivery systems market in Americas
  • Insulin delivery systems market in EMEA
  • Insulin delivery systems market in APAC

PART 09: Market drivers

  • Increase in type-1 diabetes
  • Paradigm shift of patient pool from hospitals to specialty clinics
  • Focus on self-management of diabetes

PART 10: Impact of drivers

PART 11: Market challenges

  • High cost of insulin devices and competitive pricing scenario
  • Threat of substitutes
  • Budget restrictions and stringent reimbursement policies
  • Complications and unmet needs

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Inhalers to revolutionize insulin delivery
  • Disruptive technologies
  • Strategic alliances leading to innovative insulin delivery systems

PART 14: Vendor landscape

  • Competitive scenario
  • Recent developments

PART 15: Key vendor analysis

  • Novo Nordisk
  • Sanofi
  • BD
  • Eli Lilly
  • Medtronic
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Global insulin delivery systems market
  • Exhibit 02: Segment overview
  • Exhibit 03: Product offerings
  • Exhibit 04: Global insulin delivery systems market 2015-2020 ($ billions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Product lifecycle of insulin delivery systems
  • Exhibit 07: Global insulin delivery systems market by product 2015
  • Exhibit 08: Global insulin delivery systems market by product 2020
  • Exhibit 09: Global insulin syringes market: Opportunity analysis
  • Exhibit 10: Global insulin syringes market: Metric analysis
  • Exhibit 11: Global insulin syringes market 2015-2020 ($ billions)
  • Exhibit 12: Global insulin pumps market: Opportunity analysis
  • Exhibit 13: Global insulin pumps market: Metric analysis
  • Exhibit 14: Global insulin pumps market 2015-2020 ($ billions)
  • Exhibit 15: Factors considered for making an ideal pen
  • Exhibit 16: Global insulin pens market: Opportunity analysis
  • Exhibit 17: Global insulin pens market: Metric analysis
  • Exhibit 18: Global insulin pens market 2015-2020 ($ billions)
  • Exhibit 19: Global insulin jet injectors market: Opportunity analysis
  • Exhibit 20: Global insulin jet injectors market: Metric analysis
  • Exhibit 21: Global insulin jet injectors market 2015-2020 ($ billions)
  • Exhibit 22: Global insulin delivery systems market by geography 2015
  • Exhibit 23: Global insulin delivery systems market by geography 2020
  • Exhibit 24: Global insulin delivery systems market by geography 2015-2020
  • Exhibit 25: Comparative study of diabetic population (0-14 years) in specific countries in Americas 2013 and 2015
  • Exhibit 26: Insulin delivery systems market in Americas 2015-2020 ($ billions)
  • Exhibit 27: Comparative study of diabetic population (0-14 years) in selected European countries 2013 and 2015
  • Exhibit 28: Comparative study of diabetic population (0-14 years) in selected MEA countries 2013 and 2015
  • Exhibit 29: Insulin delivery systems market in EMEA 2015-2020 ($ billions)
  • Exhibit 30: Insulin delivery systems market in APAC 2015-2020 ($ billions)
  • Exhibit 31: Comparison of type 1 diabetes incidences 2013 and 2015
  • Exhibit 32: Impact of drivers
  • Exhibit 33: Impact of drivers and challenges
  • Exhibit 34: Global insulin delivery systems market: Competitive landscape 2015
  • Exhibit 35: Recent developments
  • Exhibit 36: Ranking of vendors 2015
  • Exhibit 37: Novo Nordisk: Metric analysis
  • Exhibit 38: Sanofi: Metric analysis
  • Exhibit 39: BD: Metric analysis
  • Exhibit 40: Eli Lilly: Metric analysis
  • Exhibit 41: Medtronic: Metric analysis
  • Exhibit 42: Other prominent vendors
Back to Top